Finance
Genetics company reports second quarter 2004 financial results
Published in AIDS Weekly, August 23rd, 2004
For the second quarter of 2004, the company reported a net loss of $4.5 million, or $0.05 per share, compared to $6.9 million, or $0.13 per share for the second quarter of 2003. For the 6 months ended June 30, 2004, the company reported a net loss of $9.3 million, or $0.12 per share, compared to $7.7 million, or $0.15 per share for the same period in 2003.
Revenue for the 3 months ended June 30, 2004 increased to $2.8 million compared to $2.1 million for the second quarter of 2003, and was $4.1 million for the 6 months ended June 30, 2004, compared to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-08-23)
More Articles from AIDS Weekly
- Antiretroviral Therapy
Ritonavir/ritonavir-boosted saquinavir does not effect saquinavir action - HIV/AIDS Epidemiology
Global burden of HIV/AIDS best estimated using plausible ranges - HIV/AIDS Research
CD4 expression allows infection of CD8 cells by HIV - HIV/AIDS Research
HIV-1 subtype B mutant escapes detection in fourth-generation HIV immunoassay - HIV/AIDS Transmission
HLA-B allele-sharing associated with accelerated HIV transmission - AIDS/HIV Diagnosis
IgG-capture BED-enzyme immunoassay detects recent HIV seroconversion - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
